首页 > 最新文献

Annals of translational medicine最新文献

英文 中文
GEMPAX, do we have another second-line option after mFOLFIRINOX in pancreatic cancer?
4区 医学 Pub Date : 2025-02-28 Epub Date: 2025-02-25 DOI: 10.21037/atm-24-182
Kathleen Boyle, Kimberly J Perez
{"title":"GEMPAX, do we have another second-line option after mFOLFIRINOX in pancreatic cancer?","authors":"Kathleen Boyle, Kimberly J Perez","doi":"10.21037/atm-24-182","DOIUrl":"10.21037/atm-24-182","url":null,"abstract":"","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":"13 1","pages":"9"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921235/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of transcatheter aortic valve replacement in patients with hypertrophic cardiomyopathy: a systematic review.
4区 医学 Pub Date : 2025-02-28 Epub Date: 2025-02-25 DOI: 10.21037/atm-24-41
Karsten Parker, Abdelrahman Aljadi, Uzoma N Ibebuogu

Background: Transcatheter aortic valve replacement (TAVR) is a guideline recommended minimally invasive cardiovascular procedure used to replace severely stenosis aortic valves. Patients with severe aortic stenosis (AS) and co-existing hypertrophic cardiomyopathy (HCM), a common defect affecting the left ventricle of the heart, have been excluded from TAVR studies due to perceived challenges to optimal valve implantation in this group of patients because of the hypertrophied left ventricle that can result in an abrupt drop in afterload from a newly replaced and more efficient aortic valve. This exclusion has resulted in paucity of data on this patient population. This study aims to review outcomes in patient with HCM undergoing TAVR for severe AS.

Methods: Using the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) Statement, we performed a systematic literature search of published outcomes regarding TAVR in HCM patients to provide some insight in this patient population.

Results: Our study showed that TAVR had significantly lower rates of in-hospital mortality, bleeding requiring a blood transfusion, invasive mechanical ventilation, acute kidney injury, vascular complications, and decreased length of stay (LOS) compared to surgical aortic valve replacement (SAVR) in our study population of 836 subjects from 11 publications. Our study is not a randomized controlled trial, which limits its generalization.

Conclusions: In severe AS patients with HCM, TAVR results in better outcomes compared to surgery.

{"title":"Outcomes of transcatheter aortic valve replacement in patients with hypertrophic cardiomyopathy: a systematic review.","authors":"Karsten Parker, Abdelrahman Aljadi, Uzoma N Ibebuogu","doi":"10.21037/atm-24-41","DOIUrl":"10.21037/atm-24-41","url":null,"abstract":"<p><strong>Background: </strong>Transcatheter aortic valve replacement (TAVR) is a guideline recommended minimally invasive cardiovascular procedure used to replace severely stenosis aortic valves. Patients with severe aortic stenosis (AS) and co-existing hypertrophic cardiomyopathy (HCM), a common defect affecting the left ventricle of the heart, have been excluded from TAVR studies due to perceived challenges to optimal valve implantation in this group of patients because of the hypertrophied left ventricle that can result in an abrupt drop in afterload from a newly replaced and more efficient aortic valve. This exclusion has resulted in paucity of data on this patient population. This study aims to review outcomes in patient with HCM undergoing TAVR for severe AS.</p><p><strong>Methods: </strong>Using the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) Statement, we performed a systematic literature search of published outcomes regarding TAVR in HCM patients to provide some insight in this patient population.</p><p><strong>Results: </strong>Our study showed that TAVR had significantly lower rates of in-hospital mortality, bleeding requiring a blood transfusion, invasive mechanical ventilation, acute kidney injury, vascular complications, and decreased length of stay (LOS) compared to surgical aortic valve replacement (SAVR) in our study population of 836 subjects from 11 publications. Our study is not a randomized controlled trial, which limits its generalization.</p><p><strong>Conclusions: </strong>In severe AS patients with HCM, TAVR results in better outcomes compared to surgery.</p>","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":"13 1","pages":"6"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Connexin 43 expression in irradiated human neck skin: a prospective case-control study. 辐照人体颈部皮肤中连接蛋白 43 的表达:一项前瞻性病例对照研究。
4区 医学 Pub Date : 2025-02-28 Epub Date: 2025-02-25 DOI: 10.21037/atm-24-158
Hao Li, Jacob William Wilson, Jocelin Wei Ling Poh, Leigh Edward Madden, Timothy Cheo, Francis Cho Hao Ho, Ming Yann Lim, Yoko Wong, David Lawrence Becker

Background: Overexpression of connexin 43 (Cx43) is seen in chronic cutaneous wounds of humans, and downregulation of Cx43 expedites healing. Human epithelia that have received radiotherapy can also suffer from chronic wounds. Since increased expression of Cx43 was observed in murine skin following irradiation, we sought to confirm this in irradiated human neck skin because Cx43 inhibition may be a novel treatment of wounds in such tissue.

Methods: We prospectively recruited adult patients who underwent elective neck surgery between November 2017 and March 2018 in the Otorhinolaryngology Department of a tertiary hospital in Singapore. A sample size of five patients with prior radiotherapy to 25 controls without radiotherapy was planned a priori. Immunohistochemical staining of Cx43 was performed in the neck skin obtained from the patients and quantified under confocal microscopy. The association between demographic factors, comorbidities of the patients, and Cx43 expression was explored. Wound healing was assessed between 7 to 14 days postoperatively.

Results: Five patients received radiotherapy 9 months to 27 years before surgery. The expression of Cx43 was 94.2 vs. 146.4 pixel-area/nucleus in the epidermis with or without radiotherapy, respectively (P=0.39). The demographics and co-morbidities of the patients with or without radiotherapy were similar except for relative anemia in the patients who had radiotherapy (hemoglobin of 12.15 vs. 14.10 g/dL, P=0.02), but hemoglobin was not correlated with Cx43 expression (P=0.93). All skin incisions healed without dehiscence.

Conclusions: Previous radiotherapy may not alter Cx43 expression in human neck skin. Whether the same is true for chronic radiation-induced wounds or acute radiation-induced dermatitis should be investigated.

{"title":"Connexin 43 expression in irradiated human neck skin: a prospective case-control study.","authors":"Hao Li, Jacob William Wilson, Jocelin Wei Ling Poh, Leigh Edward Madden, Timothy Cheo, Francis Cho Hao Ho, Ming Yann Lim, Yoko Wong, David Lawrence Becker","doi":"10.21037/atm-24-158","DOIUrl":"10.21037/atm-24-158","url":null,"abstract":"<p><strong>Background: </strong>Overexpression of connexin 43 (Cx43) is seen in chronic cutaneous wounds of humans, and downregulation of Cx43 expedites healing. Human epithelia that have received radiotherapy can also suffer from chronic wounds. Since increased expression of Cx43 was observed in murine skin following irradiation, we sought to confirm this in irradiated human neck skin because Cx43 inhibition may be a novel treatment of wounds in such tissue.</p><p><strong>Methods: </strong>We prospectively recruited adult patients who underwent elective neck surgery between November 2017 and March 2018 in the Otorhinolaryngology Department of a tertiary hospital in Singapore. A sample size of five patients with prior radiotherapy to 25 controls without radiotherapy was planned a priori. Immunohistochemical staining of Cx43 was performed in the neck skin obtained from the patients and quantified under confocal microscopy. The association between demographic factors, comorbidities of the patients, and Cx43 expression was explored. Wound healing was assessed between 7 to 14 days postoperatively.</p><p><strong>Results: </strong>Five patients received radiotherapy 9 months to 27 years before surgery. The expression of Cx43 was 94.2 <i>vs.</i> 146.4 pixel-area/nucleus in the epidermis with or without radiotherapy, respectively (P=0.39). The demographics and co-morbidities of the patients with or without radiotherapy were similar except for relative anemia in the patients who had radiotherapy (hemoglobin of 12.15 <i>vs.</i> 14.10 g/dL, P=0.02), but hemoglobin was not correlated with Cx43 expression (P=0.93). All skin incisions healed without dehiscence.</p><p><strong>Conclusions: </strong>Previous radiotherapy may not alter Cx43 expression in human neck skin. Whether the same is true for chronic radiation-induced wounds or acute radiation-induced dermatitis should be investigated.</p>","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":"13 1","pages":"3"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Effect of acellular nerve scaffold containing human umbilical cord-derived mesenchymal stem cells on nerve repair and regeneration in rats with sciatic nerve defect. 更正:含人脐带间充质干细胞的细胞神经支架对坐骨神经缺损大鼠神经修复和再生的影响。
4区 医学 Pub Date : 2025-02-28 Epub Date: 2025-02-25 DOI: 10.21037/atm-2024-52

[This corrects the article DOI: 10.21037/atm-22-1578.].

{"title":"Erratum: Effect of acellular nerve scaffold containing human umbilical cord-derived mesenchymal stem cells on nerve repair and regeneration in rats with sciatic nerve defect.","authors":"","doi":"10.21037/atm-2024-52","DOIUrl":"10.21037/atm-2024-52","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.21037/atm-22-1578.].</p>","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":"13 1","pages":"e5"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Panaxdiol saponins component promotes hematopoiesis by regulating GATA transcription factors of intracellular signaling pathway in mouse bone marrow. 批注:三七皂苷成分通过调节小鼠骨髓细胞内信号通路的GATA转录因子促进造血。
4区 医学 Pub Date : 2025-02-28 Epub Date: 2025-02-25 DOI: 10.21037/atm-2024b-55

[This corrects the article DOI: 10.21037/atm-21-4800.].

{"title":"Erratum: Panaxdiol saponins component promotes hematopoiesis by regulating GATA transcription factors of intracellular signaling pathway in mouse bone marrow.","authors":"","doi":"10.21037/atm-2024b-55","DOIUrl":"10.21037/atm-2024b-55","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.21037/atm-21-4800.].</p>","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":"13 1","pages":"e3"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishing normative values for short-term heart rate variability indices in healthy infants in the emergency department. 为急诊科健康婴儿的短期心率变异性指数建立标准值。
4区 医学 Pub Date : 2025-02-28 Epub Date: 2025-02-25 DOI: 10.21037/atm-24-180
Supranee Mathiprechakul, Dagang Guo, Shu-Ling Chong, Rupini Piragasam, Marcus Eng Hock Ong, Stephanie Fook-Chong, Gene Yong-Kwang Ong

Background: Heart rate variability (HRV) has been used as a marker of cardiovascular health and a risk factor for mortality in the adult and paediatric populations, and as an indicator of neonatal sepsis. There has been an increasing interest in using short-term (5 minutes) HRV to identify infants ≤90 days of life with serious bacterial infections. However, there has not been any normative data range reported for short-term HRV indices in this infant population. The aim of this study was to evaluate short-term HRV indices in awake, healthy young infants >48 hours and ≤90 days of life and to establish a reference range. We also aimed to produce a clinical calculator that can be used in this population for evaluation of short-term HRV variables in young infants in the emergency department (ED) setting that can be potentially used in future clinical validation and research.

Methods: We conducted a prospective observational study of short-term HRV analysis of awake, well infants ≤90 days of life in the ED setting.

Results: One hundred and eight infants with complete data [51.9% male, median age 9 days (interquartile range, 4-35 days)] were included. We found that heart rate (HR) is correlated with HRV. Thus, normalisation of HRV parameters was done to remove their dependence on HR. We then provided normative reference range of widely used short-term HRV time-domain, frequency-domain, and non-linear HRV metrics in our cohort.

Conclusions: We established normative values and HRV calculator for evaluation of these short-term HRV variables in young infants in ED settings that can be used for further clinical validation and clinical research.

背景:心率变异性(HRV心率变异性(HRV)已被用作心血管健康的标志物、成人和儿童死亡率的风险因素以及新生儿败血症的指标。人们越来越关注使用短期(5 分钟)心率变异来识别出生后 90 天以内患有严重细菌感染的婴儿。然而,目前还没有关于该婴儿群体短期心率变异指数的标准数据范围的报告。本研究旨在评估出生后 48 小时以上和 90 天以下清醒、健康的年轻婴儿的短期心率变异指数,并确定参考范围。我们还旨在制作一个临床计算器,可用于在急诊科(ED)环境中评估幼婴的短期心率变异变量,该计算器可用于未来的临床验证和研究:方法:我们对急诊科环境中出生 90 天以下的清醒、健康婴儿的短期心率变异分析进行了前瞻性观察研究:结果:共纳入了 108 名数据完整的婴儿[51.9% 为男性,中位年龄为 9 天(四分位数范围为 4-35 天)]。我们发现心率(HR)与心率变异相关。因此,我们对心率变异参数进行了归一化处理,以消除其对心率的依赖性。然后,我们为队列中广泛使用的短期心率变异时域、频域和非线性心率变异指标提供了常模参考范围:结论:我们为评估 ED 环境中幼儿的这些短期心率变异变量建立了标准值和心率变异计算器,可用于进一步的临床验证和临床研究。
{"title":"Establishing normative values for short-term heart rate variability indices in healthy infants in the emergency department.","authors":"Supranee Mathiprechakul, Dagang Guo, Shu-Ling Chong, Rupini Piragasam, Marcus Eng Hock Ong, Stephanie Fook-Chong, Gene Yong-Kwang Ong","doi":"10.21037/atm-24-180","DOIUrl":"10.21037/atm-24-180","url":null,"abstract":"<p><strong>Background: </strong>Heart rate variability (HRV) has been used as a marker of cardiovascular health and a risk factor for mortality in the adult and paediatric populations, and as an indicator of neonatal sepsis. There has been an increasing interest in using short-term (5 minutes) HRV to identify infants ≤90 days of life with serious bacterial infections. However, there has not been any normative data range reported for short-term HRV indices in this infant population. The aim of this study was to evaluate short-term HRV indices in awake, healthy young infants >48 hours and ≤90 days of life and to establish a reference range. We also aimed to produce a clinical calculator that can be used in this population for evaluation of short-term HRV variables in young infants in the emergency department (ED) setting that can be potentially used in future clinical validation and research.</p><p><strong>Methods: </strong>We conducted a prospective observational study of short-term HRV analysis of awake, well infants ≤90 days of life in the ED setting.</p><p><strong>Results: </strong>One hundred and eight infants with complete data [51.9% male, median age 9 days (interquartile range, 4-35 days)] were included. We found that heart rate (HR) is correlated with HRV. Thus, normalisation of HRV parameters was done to remove their dependence on HR. We then provided normative reference range of widely used short-term HRV time-domain, frequency-domain, and non-linear HRV metrics in our cohort.</p><p><strong>Conclusions: </strong>We established normative values and HRV calculator for evaluation of these short-term HRV variables in young infants in ED settings that can be used for further clinical validation and clinical research.</p>","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":"13 1","pages":"2"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal anesthesia for hemicorporectomy suggests creating a standardized anesthesia guideline: a case report. 血液全切除术的多模式麻醉建议制定标准化麻醉指南:病例报告。
4区 医学 Pub Date : 2025-02-28 Epub Date: 2025-02-25 DOI: 10.21037/atm-24-174
Kelsey M Repine, Tobias de la Garza Eckle, Julio Montejano, Scott Vogel

Background: First performed in 1960, hemicorporectomy, or translumbar amputation, is a rare surgery performed as a last resort for patients with life-threatening diagnoses. While rare, it is associated with significant challenging events for the anesthesiologist. Here we present a challenging hemicorporectomy case which was successfully managed using a multimodal anesthesia approach.

Case description: The patient was a 40-year-old patient presenting for completion of a hemicorporectomy via a left hemipelvectomy for pelvic chondrosarcoma. The patient underwent hemicorporectomy under epidural and total intravenous anesthesia supplemented with ketamine and lidocaine infusion. The surgery lasted 17.5 h and resulted in 28 L of blood loss. The patient noted excellent pain control and was discharged on postoperative day 74 following an uncomplicated hospital course and in-house rehabilitation.

Conclusions: Reviewing the literature, we recognized that there are no standardized anesthesia protocols published for hemicorporectomy. Based on our case report we present a novel anesthesia strategy that addresses almost all major challenges with hemicorporectomies. Our successful strategy suggests that a total intravenous anesthesia with propofol in combination with an epidural and a multimodal pain regimen with rate adjustments based on body mass reduction should be considered as a standard anesthesia protocol for hemicorporectomies. We recommend establishing a state-of-the-art anesthesia guideline for patients undergoing hemicorporectomy and encourage anesthesiologists to publish case reports describing the anesthesia approach for a hemicorporectomy.

{"title":"Multimodal anesthesia for hemicorporectomy suggests creating a standardized anesthesia guideline: a case report.","authors":"Kelsey M Repine, Tobias de la Garza Eckle, Julio Montejano, Scott Vogel","doi":"10.21037/atm-24-174","DOIUrl":"10.21037/atm-24-174","url":null,"abstract":"<p><strong>Background: </strong>First performed in 1960, hemicorporectomy, or translumbar amputation, is a rare surgery performed as a last resort for patients with life-threatening diagnoses. While rare, it is associated with significant challenging events for the anesthesiologist. Here we present a challenging hemicorporectomy case which was successfully managed using a multimodal anesthesia approach.</p><p><strong>Case description: </strong>The patient was a 40-year-old patient presenting for completion of a hemicorporectomy via a left hemipelvectomy for pelvic chondrosarcoma. The patient underwent hemicorporectomy under epidural and total intravenous anesthesia supplemented with ketamine and lidocaine infusion. The surgery lasted 17.5 h and resulted in 28 L of blood loss. The patient noted excellent pain control and was discharged on postoperative day 74 following an uncomplicated hospital course and in-house rehabilitation.</p><p><strong>Conclusions: </strong>Reviewing the literature, we recognized that there are no standardized anesthesia protocols published for hemicorporectomy. Based on our case report we present a novel anesthesia strategy that addresses almost all major challenges with hemicorporectomies. Our successful strategy suggests that a total intravenous anesthesia with propofol in combination with an epidural and a multimodal pain regimen with rate adjustments based on body mass reduction should be considered as a standard anesthesia protocol for hemicorporectomies. We recommend establishing a state-of-the-art anesthesia guideline for patients undergoing hemicorporectomy and encourage anesthesiologists to publish case reports describing the anesthesia approach for a hemicorporectomy.</p>","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":"13 1","pages":"7"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921205/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of statins in tissue healing following tooth extraction: a systematic review of animal studies.
4区 医学 Pub Date : 2025-02-28 Epub Date: 2025-02-25 DOI: 10.21037/atm-24-140
Karthik Kommuri, Mayank Kakkar, Neha Mehta, Maryam Altuhafy, Pooja Gangwani, Junad Khan

Background: Statins, with their unique ability to stimulate bone formation and soft tissue healing, hold the potential to revolutionize dental care. The present study aims to delve into the profound effects of statins on bone and soft tissue healing in dental extraction sockets, offering a promising future for dental professionals and patients alike.

Methods: This systematic review aimed to understand the role of stains in tissue healing following dental extraction. This study was registered in the International Prospective Register of Ongoing Systematic Reviews (PROSPERO; CRD42022299247). A comprehensive electronic database search yielded 412 manuscripts. After a rigorous screening process, nine manuscripts met the eligibility criteria. The study sample consisted of 403 animals, with eight studies utilizing rat animal models and one conducted on mongrel dogs.

Results: Overall, the application of statin drugs holds promise for improving tissue healing outcomes following tooth extraction. The primary outcome variables across all studies were residual ridge height and width, messenger ribonucleic acid (mRNA) expression of transforming growth factor-beta 1 (TGF-β1), bone morphogenetic protein-2 (BMP-2), and vascular endothelial growth factor (VEGF), bone and gingival healing, inflammatory response, and bone turnover (BT), bone formation in tooth extraction socket, and osteogenic healing in a tooth extraction socket.

Conclusions: The findings of this study underscore the significant potential of statin drugs to enhance tissue healing outcomes following tooth extraction. This discovery opens new and exciting possibilities for improving dentistry patient care, potentially transforming how we approach post-extraction healing.

{"title":"Efficacy of statins in tissue healing following tooth extraction: a systematic review of animal studies.","authors":"Karthik Kommuri, Mayank Kakkar, Neha Mehta, Maryam Altuhafy, Pooja Gangwani, Junad Khan","doi":"10.21037/atm-24-140","DOIUrl":"10.21037/atm-24-140","url":null,"abstract":"<p><strong>Background: </strong>Statins, with their unique ability to stimulate bone formation and soft tissue healing, hold the potential to revolutionize dental care. The present study aims to delve into the profound effects of statins on bone and soft tissue healing in dental extraction sockets, offering a promising future for dental professionals and patients alike.</p><p><strong>Methods: </strong>This systematic review aimed to understand the role of stains in tissue healing following dental extraction. This study was registered in the International Prospective Register of Ongoing Systematic Reviews (PROSPERO; CRD42022299247). A comprehensive electronic database search yielded 412 manuscripts. After a rigorous screening process, nine manuscripts met the eligibility criteria. The study sample consisted of 403 animals, with eight studies utilizing rat animal models and one conducted on mongrel dogs.</p><p><strong>Results: </strong>Overall, the application of statin drugs holds promise for improving tissue healing outcomes following tooth extraction. The primary outcome variables across all studies were residual ridge height and width, messenger ribonucleic acid (mRNA) expression of transforming growth factor-beta 1 (TGF-β1), bone morphogenetic protein-2 (BMP-2), and vascular endothelial growth factor (VEGF), bone and gingival healing, inflammatory response, and bone turnover (BT), bone formation in tooth extraction socket, and osteogenic healing in a tooth extraction socket.</p><p><strong>Conclusions: </strong>The findings of this study underscore the significant potential of statin drugs to enhance tissue healing outcomes following tooth extraction. This discovery opens new and exciting possibilities for improving dentistry patient care, potentially transforming how we approach post-extraction healing.</p>","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":"13 1","pages":"5"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The SH-9Hospital knotting technique: analysis of innovation claims and biomechanical testing.
4区 医学 Pub Date : 2025-02-28 Epub Date: 2025-02-25 DOI: 10.21037/atm-24-201
Ioannis Kyriazidis, Alexandros Tassos, Juan E Berner
{"title":"The SH-9Hospital knotting technique: analysis of innovation claims and biomechanical testing.","authors":"Ioannis Kyriazidis, Alexandros Tassos, Juan E Berner","doi":"10.21037/atm-24-201","DOIUrl":"10.21037/atm-24-201","url":null,"abstract":"","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":"13 1","pages":"10"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Effects and molecular mechanisms of Achyranthes bidentata polypeptide k on proliferation of Schwann cells.
4区 医学 Pub Date : 2025-02-28 Epub Date: 2025-02-25 DOI: 10.21037/atm-2024b-61

[This corrects the article DOI: 10.21037/atm-21-5181.].

{"title":"Erratum: Effects and molecular mechanisms of <i>Achyranthes bidentata</i> polypeptide k on proliferation of Schwann cells.","authors":"","doi":"10.21037/atm-2024b-61","DOIUrl":"10.21037/atm-2024b-61","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.21037/atm-21-5181.].</p>","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":"13 1","pages":"e1"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of translational medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1